Symposium 20: Initial approach to the patient with NAFLD

Steatosis (fatty liver) is defined as fatty infiltration of more than 5% of hepatocytes. Its prevalence in the general population is approximately 30%, being higher in special populations such as diabetes and obesity. Also with greater possibility of progressing to more serious forms of the disease....

Full description

Bibliographic Details
Main Author: Adrián Narváez
Format: Article
Language:Spanish
Published: Sello Editorial Lugones 2022-09-01
Series:Revista de la Sociedad Argentina de Diabetes
Subjects:
Online Access:https://revistasad.com/index.php/diabetes/article/view/646
_version_ 1811219415783440384
author Adrián Narváez
author_facet Adrián Narváez
author_sort Adrián Narváez
collection DOAJ
description Steatosis (fatty liver) is defined as fatty infiltration of more than 5% of hepatocytes. Its prevalence in the general population is approximately 30%, being higher in special populations such as diabetes and obesity. Also with greater possibility of progressing to more serious forms of the disease. Type 2 diabetes is one of the strongest clinical predictors of progression from simple steatosis to non-alcoholic steatohepatitis (NASH) and cirrhosis.
first_indexed 2024-04-12T07:25:23Z
format Article
id doaj.art-d98558f5baeb4cd6a41b77e915d349c8
institution Directory Open Access Journal
issn 0325-5247
2346-9420
language Spanish
last_indexed 2024-04-12T07:25:23Z
publishDate 2022-09-01
publisher Sello Editorial Lugones
record_format Article
series Revista de la Sociedad Argentina de Diabetes
spelling doaj.art-d98558f5baeb4cd6a41b77e915d349c82022-12-22T03:42:13ZspaSello Editorial LugonesRevista de la Sociedad Argentina de Diabetes0325-52472346-94202022-09-01563Sup10710710.47196/diab.v56i3Sup.646560Symposium 20: Initial approach to the patient with NAFLDAdrián Narváez0Médico especialista en Hepatología y Trasplante hepático. Hospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires, ArgentinaSteatosis (fatty liver) is defined as fatty infiltration of more than 5% of hepatocytes. Its prevalence in the general population is approximately 30%, being higher in special populations such as diabetes and obesity. Also with greater possibility of progressing to more serious forms of the disease. Type 2 diabetes is one of the strongest clinical predictors of progression from simple steatosis to non-alcoholic steatohepatitis (NASH) and cirrhosis.https://revistasad.com/index.php/diabetes/article/view/646hígado graso
spellingShingle Adrián Narváez
Symposium 20: Initial approach to the patient with NAFLD
Revista de la Sociedad Argentina de Diabetes
hígado graso
title Symposium 20: Initial approach to the patient with NAFLD
title_full Symposium 20: Initial approach to the patient with NAFLD
title_fullStr Symposium 20: Initial approach to the patient with NAFLD
title_full_unstemmed Symposium 20: Initial approach to the patient with NAFLD
title_short Symposium 20: Initial approach to the patient with NAFLD
title_sort symposium 20 initial approach to the patient with nafld
topic hígado graso
url https://revistasad.com/index.php/diabetes/article/view/646
work_keys_str_mv AT adriannarvaez symposium20initialapproachtothepatientwithnafld